Mycostatin Pediatric (nystatin oral pediatric)

Mycostatin Pediatric (nystatin oral pediatric) is filed as Antifungal. The sections below restate public label fields stored for this profile.

Class
Antifungal
Generic name
nystatin oral pediatric
Route
TOPICAL
Dosage forms
HOW SUPPLIED Nyamyc® (Nystatin Topical Powder, USP) 100,000 units nystatin per gram is available as follow: Bottles of 15 g (NDC 0832-0465-15) Bottles of 30 g (NDC 0832-0465-30) Bottles of 60 g (NDC 0832-0465-60) STORAGE Nyamyc® (Nystatin Topical Powder, USP) Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Avoid excessive heat (40°C/104°F). Keep tightly closed. Keep out of reach of children. Nyamyc is a registered trademark of Upsher-Smith Laboratories, LLC.
Manufacturer
Upsher-Smith Laboratories, LLC

Approved uses

Animax Ointment is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs and in anal gland infections in dogs. The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal ( Candida albicans ) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis; and as an adjunct in the treatment of dermatitis due to parasitic infestation.

How it works

CLINICAL PHARMACOLOGY Pharmacokinetics Nystatin is not absorbed from intact skin or mucous membrane. Microbiology Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

Warnings and precautions

Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in the offspring. In dogs, other congenital anomalies have resulted: deformed forelegs, phocomelia, and anasarca. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Contraindications

Before instilling any medication into the ear, examine the external ear canal thoroughly to be certain the tympanic membrane is not ruptured in order to avoid the possibility of transmitting infection to the middle ear as well as damaging the cochlea or vestibular apparatus from prolonged contact. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue the use of Animax Ointment.

Adverse reactions

SAP and SGPT (ALT) enzyme elevations, polydipsia and polyuria, vomiting, and diarrhea (occasionally bloody) have been observed following parenteral or systemic use of synthetic corticosteroids in dogs. Cushing's syndrome has been reported in association with prolonged or repeated steroid therapy in dogs. Temporary hearing loss has been reported in conjunction with treatment of otitis with products containing corticosteroids. However, regression usually occurred following withdrawal of the drug. Hearing loss, with varying degrees of recovery, has been reported with the use of Animax Ointment. If hearing dysfunction is noted during the course of treatment with Animax Ointment, discontinue its use. To report suspected adverse drug events, for technical assistance or to obtain a copy of the safety data sheet (SDS), contact Dechra at (866) 933-2472. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/reportanimalae.

Dosage and administration

Frequency of administration is dependent on the severity of the condition. For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs. Wear gloves during the administration of the ointment or wash hands immediately after application. Otitis Clean ear canal of impacted cerumen. Inspect canal and remove any foreign bodies such as grass awns, ticks, etc. Instill three to five drops of Animax Ointment. Preliminary use of a local anesthetic may be advisable. Infected Anal Glands, Cystic Areas, etc. Drain gland or cyst and then fill with Animax Ointment. Other Dermatologic Disorders Clean affected areas, removing any encrusted discharge or exudate. Apply Animax Ointment sparingly in a thin film.

Common questions

What is Mycostatin Pediatric approved to treat?

According to its FDA label, Mycostatin Pediatric (nystatin oral pediatric) is approved for: Animax Ointment is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs and in anal gland infections in dogs. The preparation is also indicated in the management of dermatologic disorders characterized by in… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Mycostatin Pediatric?

Mycostatin Pediatric (nystatin oral pediatric) belongs to the Antifungal class of medications.

What form does Mycostatin Pediatric come in?

The FDA label lists Mycostatin Pediatric (nystatin oral pediatric) as: HOW SUPPLIED Nyamyc® (Nystatin Topical Powder, USP) 100,000 units nystatin per gram is available as follow: Bottles of 15 g (NDC 0832-0465-15) Bottles of 30 g (NDC 0832-0465-30) Bottles of 60 g (NDC 0832-0465-60) STORAGE Nyamyc® (Nystatin Topical Powder, USP) Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Avoid excessive heat (40°C/104°F). Keep tightly closed. Keep out of reach of children. Nyamyc is a registered trademark of Upsher-Smith Laboratories, LLC.; topical route. Available strengths and packaging vary by manufacturer.

Does Mycostatin Pediatric have a Boxed Warning?

Our ingest of the FDA label for Mycostatin Pediatric (nystatin oral pediatric) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does Mycostatin Pediatric cost?

Public CMS NADAC pricing for Mycostatin Pediatric (nystatin oral pediatric) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Mycostatin Pediatric currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Mycostatin Pediatric (nystatin oral pediatric) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Mycostatin Pediatric approved by the FDA?

The FDA record lists the approval date for Mycostatin Pediatric (nystatin oral pediatric) as 2005-05-03.

Who makes Mycostatin Pediatric?

The FDA label lists Upsher-Smith Laboratories, LLC as a labeler/manufacturer of Mycostatin Pediatric (nystatin oral pediatric). Multiple firms may market generics of the same molecule.

How should Mycostatin Pediatric be stored?

The FDA label states: "Animax Ointment is supplied in tubes as follows: 7.5 mL tubes NDC 17033-122-75 15 mL tubes NDC 17033-122-15 30 mL tubes NDC 17033-122-30 STORAGE: Store at room temperature; avoid excessive heat (104°F)." Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…